AAMC News - March 13, 2024
Fourth-year Einstein medical student Julia McMillan Castellano, a professional dancer, says physicians' artistic endeavors can serve to remind them of their calling to help patients become healthier and pursue their own passions.
Additional coverage includes MedPage Today and News12
The New York Times - March 8, 2024
Mirnova Ceide, M.D., M.S., discusses the importance of having detailed discussions about end-of-life planning, health care proxies, and living wills for older family members. Dr. Ceide is associate professor of psychiatry and behavioral sciences and of medicine at Einstein, and a psychiatrist at Montefiore.
Dr. Ceide's Profile
The New York Times - February 26, 2024
Ruth Gottesman, Ed.D., chair of the Einstein Board of Trustees and Montefiore Health System board member, has donated $1 billion dollars to Einstein— the largest gift made to any medical school in the country—ensuring free tuition in perpetuity. Dr. Gottesman is also professor emerita of pediatrics.
Additional coverage includes The Wall Street Journal, The Washington Post, The Associated Press, CBS News, ABC News, NBC New York, BBC, The Guardian, Forbes, Fortune, and The Hill
Dr. Gottesman's Profile
Technology Networks - February 16, 2024
Xingxing Zang, Ph.D., says chimeric antigen receptor (CAR)-immune cell therapy, particularly CAR-T therapy, is a major advancing field with potential to revolutionize cancer treatment, particularly for leukemia and lymphoma. Dr. Zang is a member of the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC), and professor of microbiology & immunology, of oncology, of medicine, and of urology, and the Louis Goldstein Swan Chair in Cancer Research at Einstein.
Zang's Profile
CNN - February 9, 2024
Nir Barzilai, M.D., says 2024 presidential candidates Joe Biden and Donald Trump, whose parents lived over 90, may be aging more slowly than people who do not have longevity in their family. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
WNYC - February 1, 2024
Kathryn Anastos, M.D., recounts her work as an activist during the early days of the AIDS epidemic in New York City, and her efforts to educate others and push for studies about HIV and women. Dr. Anastos is professor of medicine, of epidemiology & population health, and of obstetrics & gynecology and women's health and associate director of global health at the Montefiore Einstein Comprehensive Cancer Center.
Dr. Anastos' Profile
ABC News - January 31, 2024
Lynne Holden, M.D., discusses a partnership between Einstein and Mentoring in Medicine that introduces Bronx high school students to careers in medicine and healthcare through hands-on EMT training. Dr. Holden is professor of emergency medicine and senior associate dean for diversity and inclusion at Einstein and an emergency medicine physician at Montefiore.
Dr. Holden's ProfileMore coverage on Dr. Holden
Newsweek - January 22, 2024
Qibin Qi, Ph.D., says findings of a new study he led about milk intake and diabetes risk can shed light on how milk affects human metabolic health. Dr. Qi is professor of epidemiology & population health and a member of the Montefiore Einstein Comprehensive Cancer Center.
Dr. Qi's ProfileMore coverage on Dr. Qi
OncLive - January 18, 2024
Susan Klugman, M.D., writes about Montefiore Einstein's leadership in educating patients and physicians about the importance of genetic testing, particularly for people who have a family history of cancer. Dr. Klugman is professor of pediatrics and of obstetrics & gynecology and women's health at Einstein, and director of reproductive and medical genetics at Montefiore.
Dr. Klugman's ProfileMore coverage on Dr. Klugman
Everyday Health - January 18, 2024
Brandilyn Peters-Samuelson, Ph.D., explains that higher estrogen in women is associated with greater microbial diversity, which is beneficial for their general health. Dr. Peters-Samuelson is assistant professor of epidemiology & population health at Einstein.
Dr. Peters-Samuelson's Profile
The New York Times - January 12, 2024
Nir Barzilai, M.D., says large, randomized controlled clinical trials are needed to determine if interventions purporting to promote longevity are effective. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Additional coverage includes The Guardian
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
Today - January 4, 2024
Thomas Ullman, M.D., explains how he treats patients with ulcerative colitis and how they can manage their condition to minimize its effects. Dr Ullman is professor of medicine at Einstein, chief of the division of gastroenterology, and a gastroenterologist at Montefiore.
Dr. Ullman's Profile
MedPageToday - January 2, 2024
An opinion piece on artificial intelligence quotes an Einstein Doctor's Tablet blog by Simon Spivack, M.D., M.P.H., who writes that technology cannot replace the necessary human connection between patients and physicians. Dr. Spivack is professor of medicine, of epidemiology & population health, and of genetics at Einstein, and a pulmonologist at Montefiore.
Dr. Spivack's ProfileMore coverage on Dr. Spivack
Science News - December 8, 2023
Kerry Morrone, M.D., talks about the benefits of a new CRISPR treatment for sickle-cell disease and the importance of ensuring health equity for patients around the world who need treatment and care. Dr. Morrone is assistant professor of pediatrics at Einstein and director of the Sickle-Cell Program at the Children's Hospital at Montefiore.
Dr. Morrone's ProfileMore coverage on Dr. Morrone
December 13, 2012
MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is professor and chair of ophthalmology and visual sciences and the Paul Henkind Chair in Ophthalmology at Einstein and Montefiore.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
October 24, 2012
Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons
August 27, 2012
American Medical News interviews Robert Marion, M.D., about prenatal whole genome sequencing, which can identify an unborn child’s risk of developing chronic diseases. Because this new test will provide detailed information on mutations of 20,000 to 25,000 genes, some of which will not be significant, Dr. Marion stresses the importance of preparing healthcare professionals to counsel expectant parents about the results. Dr. Marion is director of Einstein’s Children's Evaluation and Rehabilitation Center and chief of developmental medicine at Einstein and Montefiore Medical Center.
Dr. Marion's ProfileMore coverage on Dr. Marion
April 25, 2012
The Journal of the National Cancer Institute interviews Geoffrey Kabat, Ph.D., on the difficulty of proving the link between bishpenol A (BPA), a common chemical in homes and food containers, and cancer risk. Dr. Kabat notes that politics can trump science when enormous public concern exists about an issue, particularly when it potentially effects infants, like BPA. Dr. Kabat is a senior epidemiologist at Einstein.
March 13, 2012
New Scientist interviews Vern Schramm, Ph.D., about his research on transition state analogs, a class of drugs he has been developing that target and neutralize specific enzymes in order to combat disease. Dr. Schramm is professor and Ruth Merns Chair in Biochemistry at Einstein.
Dr.Schramm's ProfileMore coverage on Dr.Schramm
February 1, 2012
Arthritis Today interviews Dr. Anna Broder regarding her research that found continued treatment may help extend the lives of lupus patients with end-stage renal disease. Dr. Broder is assistant professor of medicine.
Dr.Broder's ProfileMore coverage on Dr.Broder
Newsweek - February 1, 2012
Microbe features research by Liise-Anne Pirofski , M.D., about a newly identified antibody that works against pneumococcal bacteria and could help to improve vaccines against pneumonia. Dr. Pirofski is chief of the division of infectious diseases at Einstein and Montefiore Medical Center and the Selma and Dr. Jacques Mitrani Professor in Biomedical Research.
Dr.Pirofski's ProfileMore coverage on Dr.Pirofski